BAKER BROS. ADVISORS LP Q2 2019 Filing

Filed August 14, 2019

Portfolio Value

$14.7B

Holdings

103

Report Date

Q2 2019

Filing Type

13F-HR

All Holdings (103 positions)

#	Stock	Shares	Value	% Portfolio
101	—Ritter Pharmaceuticals, Inc.	279,999	$300K	0.00%
102	DVAXDynavax Technologies Corporation	75,000	$299K	0.00%
103	TREURTrillium Therapeutics Inc.	505,262	$166K	0.00%

PreviousPage 2 of 2